Literature DB >> 29532809

Editorial on PanCan study.

Henry M Marshall1, Ian A Yang1, Rayleen V Bowman1, Kwun M Fong1.   

Abstract

Year:  2018        PMID： 29532809      PMCID： PMC5835627          DOI： 10.21037/tlcr.2018.01.17

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  12 in total

1.  The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency.

Authors:  Sonya Cressman; Stuart J Peacock; Martin C Tammemägi; William K Evans; Natasha B Leighl; John R Goffin; Alain Tremblay; Geoffrey Liu; Daria Manos; Paul MacEachern; Rick Bhatia; Serge Puksa; Garth Nicholas; Annette McWilliams; John R Mayo; John Yee; John C English; Reka Pataky; Emily McPherson; Sukhinder Atkar-Khattra; Michael R Johnston; Heidi Schmidt; Frances A Shepherd; Kam Soghrati; Kayvan Amjadi; Paul Burrowes; Christian Couture; Harmanjatinder S Sekhon; Kazuhiro Yasufuku; Glenwood Goss; Diana N Ionescu; David M Hwang; Simon Martel; Don D Sin; Wan C Tan; Stefan Urbanski; Zhaolin Xu; Ming-Sound Tsao; Stephen Lam
Journal:  J Thorac Oncol       Date:  2017-05-10       Impact factor: 15.609

2.  Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.

Authors:  Kuanrong Li; Anika Hüsing; Disorn Sookthai; Manuela Bergmann; Heiner Boeing; Nikolaus Becker; Rudolf Kaaks
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-15

3.  Cost-effectiveness of CT screening in the National Lung Screening Trial.

Authors:  William C Black; Ilana F Gareen; Samir S Soneji; JoRean D Sicks; Emmett B Keeler; Denise R Aberle; Arash Naeim; Timothy R Church; Gerard A Silvestri; Jeremy Gorelick; Constantine Gatsonis
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

4.  Selection criteria for lung-cancer screening.

Authors:  Martin C Tammemägi; Hormuzd A Katki; William G Hocking; Timothy R Church; Neil Caporaso; Paul A Kvale; Anil K Chaturvedi; Gerard A Silvestri; Tom L Riley; John Commins; Christine D Berg
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

5.  Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study.

Authors:  Martin Carl Tammemagi; Matthew T Freedman; Paul F Pinsky; Martin M Oken; Ping Hu; Thomas L Riley; Lawrence R Ragard; Christine D Berg; Philip C Prorok
Journal:  J Thorac Oncol       Date:  2009-06       Impact factor: 15.609

6.  Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.

Authors:  Martin C Tammemagi; Heidi Schmidt; Simon Martel; Annette McWilliams; John R Goffin; Michael R Johnston; Garth Nicholas; Alain Tremblay; Rick Bhatia; Geoffrey Liu; Kam Soghrati; Kazuhiro Yasufuku; David M Hwang; Francis Laberge; Michel Gingras; Sergio Pasian; Christian Couture; John R Mayo; Paola V Nasute Fauerbach; Sukhinder Atkar-Khattra; Stuart J Peacock; Sonya Cressman; Diana Ionescu; John C English; Richard J Finley; John Yee; Serge Puksa; Lori Stewart; Scott Tsai; Ehsan Haider; Colm Boylan; Jean-Claude Cutz; Daria Manos; Zhaolin Xu; Glenwood D Goss; Jean M Seely; Kayvan Amjadi; Harmanjatinder S Sekhon; Paul Burrowes; Paul MacEachern; Stefan Urbanski; Don D Sin; Wan C Tan; Natasha B Leighl; Frances A Shepherd; William K Evans; Ming-Sound Tsao; Stephen Lam
Journal:  Lancet Oncol       Date:  2017-10-18       Impact factor: 41.316

7.  Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.

Authors:  Martin C Tammemägi; Timothy R Church; William G Hocking; Gerard A Silvestri; Paul A Kvale; Thomas L Riley; John Commins; Christine D Berg
Journal:  PLoS Med       Date:  2014-12-02       Impact factor: 11.069

8.  Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.

Authors:  Kevin Ten Haaf; Jihyoun Jeon; Martin C Tammemägi; Summer S Han; Chung Yin Kong; Sylvia K Plevritis; Eric J Feuer; Harry J de Koning; Ewout W Steyerberg; Rafael Meza
Journal:  PLoS Med       Date:  2017-04-04       Impact factor: 11.069

9.  Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.

Authors:  Sonya Cressman; Stephen Lam; Martin C Tammemagi; William K Evans; Natasha B Leighl; Dean A Regier; Corneliu Bolbocean; Frances A Shepherd; Ming-Sound Tsao; Daria Manos; Geoffrey Liu; Sukhinder Atkar-Khattra; Ian Cromwell; Michael R Johnston; John R Mayo; Annette McWilliams; Christian Couture; John C English; John Goffin; David M Hwang; Serge Puksa; Heidi Roberts; Alain Tremblay; Paul MacEachern; Paul Burrowes; Rick Bhatia; Richard J Finley; Glenwood D Goss; Garth Nicholas; Jean M Seely; Harmanjatinder S Sekhon; John Yee; Kayvan Amjadi; Jean-Claude Cutz; Diana N Ionescu; Kazuhiro Yasufuku; Simon Martel; Kamyar Soghrati; Don D Sin; Wan C Tan; Stefan Urbanski; Zhaolin Xu; Stuart J Peacock
Journal:  J Thorac Oncol       Date:  2014-10       Impact factor: 15.609

10.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Authors:  J K Field; S W Duffy; D R Baldwin; D K Whynes; A Devaraj; K E Brain; T Eisen; J Gosney; B A Green; J A Holemans; T Kavanagh; K M Kerr; M Ledson; K J Lifford; F E McRonald; A Nair; R D Page; M K B Parmar; D M Rassl; R C Rintoul; N J Screaton; N J Wald; D Weller; P R Williamson; G Yadegarfar; D M Hansell
Journal:  Thorax       Date:  2015-12-08       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.